News Sentiment

ELV sentiment intelligence

Elevance Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 61 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Healthcare Plans Read-through group
Latest close 416.23 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

77/100 classification confidence.

Company focus 61

directly relevant articles

Source quality 10

high-authority source matches

Trend context Trend active

-0.4% over one week, +3.0% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets

Market Reaction

Balanced read

49/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 77/100 classification
One-week reaction -0.4% Price digesting
Trend fit Trend active 3.0% over four weeks
Fair value 2.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 29
Negative 13

Relevance

Why the article matched

Direct first
Direct company coverage 61
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 7
Stock Titan 7
Market source 6
Investing.com 3
TradingView 3
Quartr 2
GuruFocus 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Earnings 30
Market update 21
Guidance 4
Analyst action 3
Deals and strategy 2
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 61
Reuters Direct company coverage

Elevance raises annual profit forecast on better medical cost management

Elevance Health has increased its annual profit forecast after exceeding second-quarter earnings expectations. This positive outlook is attributed to the company's effective medical cost management strategies. The insurer also reported a better-than-expected medical loss ratio, i

Tone
Positive 82/100
Event
Earnings
Published
15 Jul 2026 10:38
Source
Reuters
Intellectia AI Direct company coverage

Elevance Health Q2 Earnings Exceed Expectations

Elevance Health reported strong Q2 2026 earnings, surpassing expectations with a non-GAAP EPS of $7.45 and revenue of $49.83 billion. The company also upgraded its full-year 2026 diluted EPS and operating cash flow guidance, indicating a positive outlook. Analysts largely maintai

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 10:09
Source
Intellectia AI
TradingView Direct company coverage

Elevance Health reports Q2 2026: Revenue $49.8B, Adj. diluted EPS $7.45, raises FY guidance

Elevance Health reported strong Q2 2026 results, with operating revenue reaching $49.8 billion and adjusted diluted EPS of $7.45. The company has raised its full-year 2026 guidance, projecting at least $20.10 diluted EPS and $27.00 adjusted diluted EPS, citing positive benefit ex

Tone
Positive 74/100
Event
Earnings
Published
15 Jul 2026 10:09
Source
TradingView
Bloomberg.com Direct company coverage

Elevance Raises Guidance on Lower-Than-Expected Medical Costs

Elevance Health Inc. has raised its annual profit guidance for the second consecutive quarter, signaling a positive trend for the health insurance industry amidst recent federal policy adjustments. The company now forecasts full-year adjusted earnings of at least $27 per share, a

Tone
Positive 71/100
Event
Guidance
Published
15 Jul 2026 10:08
Source
Bloomberg.com
Stock Titan Direct company coverage

Elevance Health (NYSE: ELV) lifts 2026 EPS guidance on Q2 results

Elevance Health reported strong Q2 2026 results, exceeding expectations with operating revenue of $49.8 billion. The company raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, along with increasing operating cas

Tone
Positive 69/100
Event
Earnings
Published
15 Jul 2026 10:08
Source
Stock Titan
Investing.com Direct company coverage

Elevance Health beats estimates but shares fall on margin concerns

Elevance Health Inc. reported Q2 results that exceeded analyst expectations for adjusted EPS and revenue. However, shares fell more than 9% premarket due to concerns over declining operating margins, which dropped to 3.5% from 4.9% in the prior year quarter. Despite this, the com

Tone
Negative 36/100
Event
Earnings
Published
15 Jul 2026 10:08
Source
Investing.com
Stock Titan Direct company coverage

Elevance Health Reports $49.8B Revenue as Medical Costs Rise

Elevance Health reported Q2 2026 operating revenue of $49.8 billion, a 0.8% increase from the prior year, exceeding expectations. The company raised its full-year adjusted EPS guidance to at least $27.00, attributing it to strong operating results and strategic investments in med

Tone
Positive 69/100
Event
Earnings
Published
15 Jul 2026 09:59
Source
Stock Titan
Modern Healthcare Direct company coverage

Health system finances feeling the squeeze from federal policy

The financial health of hospital systems is under stress due to federal policy, with HCA Healthcare's Affordable Care Act losses highlighting a broader industry strain. Patients facing increased healthcare costs are opting for different plans or leaving the insurance market entir

Tone
Negative 29/100
Event
Market update
Published
15 Jul 2026 09:40
Source
Modern Healthcare
Simply Wall Street Direct company coverage

How Expanded Coverage for Guardant’s Shield Test Will Impact UnitedHealth Group (UNH) Investors

UnitedHealth Group (UNH) has expanded coverage for Guardant Health Inc.'s Shield blood test for colorectal cancer screening to roughly 40 million eligible members. This move aligns with UNH's focus on preventive care but is unlikely to immediately outweigh issues like Medicare Ad

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 05:09
Source
Simply Wall Street
Moomoo Direct company coverage

Jefferies Adjusts Price Target on Elevance Health to $393 From $391, Maintains Buy Rating

Jefferies has adjusted its price target for Elevance Health (ELV) to $393, an increase from its previous target of $391. The firm has also reiterated its Buy rating on the healthcare company's stock. This modest price target revision indicates continued confidence in Elevance Hea

Tone
Positive 67/100
Event
Analyst action
Published
14 Jul 2026 15:08
Source
Moomoo